[1] WANG QX,YAN L,MA X. Autoimmune hepatitis in the AsiaPacific area[J]. J Clin Transl Hepatol,2018,6(1):48-56.
|
[2] MACKAY IR. Historical reflections on autoimmune hepatitis[J]. World J Gastroenterol,2008,14(21):3292-3300.
|
[3] ROBERTS SK,KEMP W. Salvage therapies for autoimmune hepatitis:A critical review[J]. Semin Liver Dis,2017,37(4):343-362.
|
[4] FLOREANI A,RESTREPO-JIMNEZ P,SECCHI MF,et al.Etiopathogenesis of autoimmune hepatitis[J]. J Autoimmun,2018,95:133-143.
|
[5] TERZIROLI BERETTA-PICCOLI B,MIELI-VERGANI G,VERGANI D. Autoimmune hepatitis:Standard treatment and systematic review of alternative treatments[J]. World J Gastroenterol,2017,23(33):6030-6048.
|
[6] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015)[J].临床肝胆病杂志,2016,32(1):9-22.
|
[7] European Association for the Study of the Liver. EASL clinical practice guidelines:Autoimmune hepatitis[J]. J Hepatol,2015,63(4):971-1004.
|
[8] SONTHALIA N,RATHI PM,JAIN SS,et al. Natural history and treatment outcomes of severe autoimmune hepatitis[J]. J Clin Gastroenterol,2017,51(6):548-556.
|
[9] LOWE D,JOHN S. Autoimmune hepatitis:Appraisal of current treatment guidelines[J]. World J Hepatol,2018,10(12):911-923.
|
[10] LIWINSKI T,SCHRAMM C. Autoimmune hepatitis-update on clinical management in 2017[J]. Clin Res Hepatol Gastroenterol,2017,41(6):617-625.
|
[11] PEISELER M,LIEBSCHER T,SEBODE M,et al. Efficacy and limitations of budesonide as a second-line treatment for patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2018,16(2):260-267.
|
[12] LU FB,HU ED,XU LM,et al. Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis:A systematic review and network meta-analysis[J]. Exp Ther Med,2018,15(6):4838-4850.
|
[13] JANMOHAMED A,HIRSCHFIELD GM. Autoimmune hepatitis and complexities in management[J]. Frontline Gastroenterol,2019,10(1):77-87.
|
[14] CROPLEY A,WELTMAN M. The use of immunosuppression in autoimmune hepatitis:A current literature review[J]. Clin Mol Hepatol,2017,23(1):22-26.
|
[15] HANOUNEH M,RITCHIE MM,ASCHA M,et al. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis[J]. Scand J Gastroenterol,2019,54(1):76-80.
|
[16] LEGUC,LEGROS L,KAMMERER-JACQUET S,et al.Safety and efficacy of 6-thioguanine as a second-line treatment for autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2018,16(2):290-291.
|
[17] DOYCHEVA I,WATT KD,GULAMHUSEIN AF. Autoimmune hepatitis:Current and future therapeutic options[J]. Liver Int,2019,39(6):1002-1013.
|
[18] TAUBERT R,HUPA-BREIER KL,JAECKEL E,et al. Novel therapeutic targets in autoimmune hepatitis[J]. J Autoimmun,2018,95:34-46.
|
[19] JONES D,MANNS MP,TERRACCIANO L,et al. Unmet needs and new models for future trials in autoimmune hepatitis[J]. Lancet Gastroenterol Hepatol,2018,3(5):363-370.
|
[20] PU SB,WANG JB,WANG RL,et al. Advantages and challenges of treatment on autoimmune hepatitis by traditional Chinese medicine and integrative medicine[J]. Chin J Exp Med Formul,2016,22(23):197-202.(in Chinese)浦仕彪,王伽伯,王睿林,等.中医和中西医结合治疗自身免疫性肝炎的优势与挑战[J].中国实验方剂学杂志,2016,22(23):197-202.
|
[21] SHEN HZ,ZHANG L. Recent progress in integrated Chinese and Western medicine treatment of autoimmune hepatitis[J].Shanghai Med Pharm J,2019,40(5):6-9,70.(in Chinese)沈含章,张乐.自身免疫性肝炎及其中西医结合治疗的研究进展[J].上海医药,2019,40(5):6-9,70.
|
[22] WANG Y,ZHENG W,MA JF,et al. Literature metrology research for the treatment of autoimmune hepatitis by traditional Chinese medicine[J]. Chin Arch Tradit Chin Med,2016,34(12):2861-2864.(in Chinese)王颖,郑炜,马俊福,等.中医药治疗自身免疫性肝炎的文献计量研究[J].中华中医药学刊,2016,34(12):2861-2864.
|
[23] QIAN JH,WEI MM,SONG MD,et al. Characteristics and curative effect of TCM differentiation and treatment of autoimmune hepatitis[J]. Chin Arch Tradit Chin Med,2017,35(10):2651-2653.(in Chinese)钱金花,魏美美,宋梦蝶,等.自身免疫性肝炎的中医辨证治疗用药特点及疗效[J].中华中医药学刊,2017,35(10):2651-2653.
|
[24] ZHU CJ,WU ZY,YE YY. Clinical effect of integrated traditional Chinese and Western medicine therapy for autoimmune hepatitis[J]. J Emerg Tradit Chin Med,2015,24(1):173-175.(in Chinese)朱常江,吴镇印,叶映月.中西医结合治疗自身免疫性肝炎的临床观察[J].中国中医急症,2015,24(1):173-175.
|
[25] CHEN Y,WU ZZ,RUAN B. Clinical effect of integrated traditional Chinese and Western medicine therapy for autoimmune hepatitis:A meta-analysis[J]. Zhejiang J Integr Tradit Chin West Med,2019,29(3):244-250.(in Chinese)陈意,吴珍珠,阮冰.中西医结合治疗自身免疫性肝炎疗效的Meta分析[J].浙江中西医结合杂志,2019,29(3):244-250.
|
[26] KERKAR N,YANNI G.‘De novo’and ‘recurrent’autoimmune hepatitis after liver transplantation:A comprehensive review[J]. J Autoimmun,2016,66:17-24.
|
[27] CHO CW,KWON CHD,KIM JM,et al. Comparative analysis of the clinical outcomes of liver transplantation for probable and definite auto-immune hepatitis by international diagnostic scoring criteria[J]. Transplant Proc,2017,49(5):1126-1128.
|
[28] STIRNIMANN G,EBADI M,CZAJA AJ,et al. Recurrent and de novo autoimmune hepatitis[J]. Liver Transpl,2019,25(1):152-166.
|